We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
Cap. Flow
-$3.3B
Cap. Flow %
-4.75%
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76

Top Sells

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$1.05B
2
MRK icon
Merck
MRK
+$702M
3
BAC icon
Bank of America
BAC
+$542M
4
ORCL icon
Oracle
ORCL
+$528M
5
STLD icon
Steel Dynamics
STLD
+$499M

Sector Composition

Rank Sector Weight
1 Financials 26.74%
2 Healthcare 14.95%
3 Industrials 13.38%
4 Technology 12.24%
5 Energy 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
226
Walmart Inc
WMT
$820B
$56M 0.08%
1,803,240
-657,165
-27% -$21.1M
SWKS icon
227
Skyworks Solutions
SWKS
$9.74B
$55.8M 0.08%
832,881
+199,834
+32% +$15.4M
NNI icon
228
Nelnet
NNI
$4.58B
$54.9M 0.08%
1,048,779
-119,779
-10% -$6.45M
COR icon
229
Cencora
COR
$61.5B
$54.1M 0.08%
+726,826
New +$62.7M
BIIB icon
230
Biogen
BIIB
$32.1B
$53M 0.08%
176,007
+3,920
+2% +$1.25M
ESNT icon
231
Essent Group
ESNT
$6.22B
$52.8M 0.08%
1,543,854
+74,129
+5% +$2.83M
VVV icon
232
Valvoline
VVV
$4.07B
$50.9M 0.07%
2,628,915
+152,295
+6% +$3.04M
SHOO icon
233
Steven Madden
SHOO
$3.27B
$46.7M 0.07%
1,542,402
-213,851
-12% -$6.58M
FCN icon
234
FTI Consulting
FCN
$4.23B
$46.4M 0.07%
696,467
+41,156
+6% +$2.76M
AMCX icon
235
AMC Global Media
AMCX
$520M
$46.3M 0.07%
842,756
+51,602
+7% +$3.02M
SKX
236
DELISTED
Skechers
SKX
$44.8M 0.06%
1,955,660
+514,734
+36% +$13.5M
ABBV icon
237
AbbVie
ABBV
$454B
$44.5M 0.06%
482,707
+479,461
+14,771% +$42.2M
SCHW
238
Charles Schwab
SCHW
$191B
$43.9M 0.06%
1,057,300
-359,457
-25% -$16.3M
STWD icon
239
Starwood Property Trust
STWD
$5.9B
$43.8M 0.06%
2,223,592
+148,174
+7% +$3.2M
LCII icon
240
LCI Industries
LCII
$2.49B
$43.4M 0.06%
649,830
+123,129
+23% +$8.97M
BXMT icon
241
Blackstone Mortgage Trust
BXMT
$2.31B
$42.8M 0.06%
1,342,231
+85,625
+7% +$2.9M
NSIT icon
242
Insight Enterprises
NSIT
$4.57B
$42.2M 0.06%
1,036,280
+34,254
+3% +$1.58M
MFA
243
MFA Financial
MFA
$893M
$41.6M 0.06%
1,557,190
+191,718
+14% +$5.38M
TTEC icon
244
TTEC Holdings
TTEC
$68.5M
$41.3M 0.06%
1,444,015
+85,541
+6% +$2.27M
CDW icon
245
CDW
CDW
$18.4B
$41.1M 0.06%
507,516
-15,769
-3% -$1.36M
SXC icon
246
SunCoke Energy
SXC
$860M
$40.7M 0.06%
4,759,842
+278,467
+6% +$2.85M
BKU icon
247
Bankunited
BKU
$3.29B
$39.9M 0.06%
1,333,394
+84,830
+7% +$2.76M
CHE icon
248
Chemed
CHE
$6.85B
$39.7M 0.06%
140,038
-14,860
-10% -$4.48M
TTEK icon
249
Tetra Tech
TTEK
$9.4B
$38.1M 0.05%
3,680,085
-1,415,295
-28% -$17.6M
TX icon
250
Ternium
TX
$10.7B
$37.6M 0.05%
1,386,505
+64,975
+5% +$1.94M

Similar funds

Boston Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.

  • Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
  • Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
  • Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
  • Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
  • Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
  • Boston Partners opened 83 new positions and closed 76 in Q4 2018.
  • Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.

Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.